BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Psychiatry. May 19, 2026; 16(5): 117187
Published online May 19, 2026. doi: 10.5498/wjp.v16.i5.117187
Table 1 Comparison of clinicopathological parameters between alcohol dehydrogenase 4 high and low expression groups, n (%)/mean ± SD
Clinicopathological parameter
High expression (n = 74)
Low expression/negative (n = 74)
Statistical value (t or χ² or Z)
P value
Age (years)52.3 ± 8.553.1 ± 9.2-0.5820.561
Male52 (70.3)54 (73.0)0.2570.612
Tumor size (cm)4.5 ± 1.86.2 ± 2.5-4.218< 0.001
Tumor size
< 5 cm47 (62.8)28 (37.8)10.3240.001
≥ 5 cm27 (37.2)46 (62.2)
Tumor number2.8360.092
Single58 (78.4)49 (66.2)
Multiple16 (21.6)25 (33.8)
Differentiation degree0.432< 0.001
Well20 (27.0)6 (8.1)
Moderate38 (51.4)30 (40.5)
Poor16 (21.6)38 (51.4)
Microvascular invasion22.563< 0.001
Yes24 (32.4)54 (73.0)
No50 (67.6)20 (27.0)
Hepatitis B virus infection0.0850.770
Positive61 (82.4)62 (83.8)
Negative13 (17.6)12 (16.2)
Cirrhosis0.3650.546
Yes45 (60.8)48 (64.9)
No29 (39.2)26 (35.1)
1-year survival61 (82.4)45 (60.8)15.347< 0.001
3-year survival41 (55.4)22 (29.7)--
Recurrence status10.0720.001
Recurred26 (35.1)45 (60.8)
Not recurred48 (64.9)29 (39.2)
Median survival time (months)38.2 ± 4.525.6 ± 3.84.893< 0.001
Table 2 Cox regression analysis of alcohol dehydrogenase 4 expression and survival prognosis
Factor
Univariate HR (95%CI)
Multivariate HR (95%CI)
Alcohol dehydrogenase 4 low expression0.402 (0.268-0.603)0.486 (0.305-0.775)
Large tumor size2.135 (1.426-3.192)1.768 (1.135-2.750)
Microvascular invasion positive2.568 (1.734-3.797)2.047 (1.315-3.186)


Write to the Help Desk